MedTrace Logo

Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success

NCT03174860 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-07-19

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of preoperative Diclofenac Potassium (50 mg Cataflam) on the anesthetic success of buccal infiltration with 4% articaine with epinephrine 1:200,000 in mandibular molars with symptomatic irreversible pulpitis.

Conditions

  • Pulpitis - Irreversible
  • Anesthesia, Local

Interventions

DRUG

Diclofenac Potassium 50mg Tab

A 50 mg tablet of the medication to be taken one hour before initiation of endodontic treatment.

DRUG

Placebo

A placebo will be taken one hour before initiation of endodontic treatment.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amatallah H Al-Rawhani, Postgraduate · Faculty of Oral and Dental Medicine/ Cairo University.

  • Dr. Suzan AW Amin, PhD · Faculty of Oral and Dental Medicine/ Cairo University.

  • Shaima'a Gawdat, PhD · Faculty of Oral and Dental Medicine/ Cairo University.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-02-28
Completion
2018-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03174860 on ClinicalTrials.gov